Business Description
SMS Lifesciences India Ltd
ISIN : INE320X01016
Compare
Compare
Traded in other countries / regions
540679.India IPO Date
2017-08-17Description
SMS Lifesciences India Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The Company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 1.82 | |||||
| Interest Coverage | 3.22 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.19 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.2 | |||||
| 3-Year EBITDA Growth Rate | 3.2 | |||||
| 3-Year EPS without NRI Growth Rate | -12.4 | |||||
| 3-Year Book Growth Rate | 11 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.75 | |||||
| 9-Day RSI | 46.97 | |||||
| 14-Day RSI | 42.09 | |||||
| 6-1 Month Momentum % | 106.2 | |||||
| 12-1 Month Momentum % | 173.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 0.58 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 126.89 | |||||
| Days Sales Outstanding | 63.12 | |||||
| Days Payable | 88.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.13 | |||||
| Dividend Payout Ratio | 0.02 | |||||
| Forward Dividend Yield % | 0.13 | |||||
| 5-Year Yield-on-Cost % | 0.14 | |||||
| Shareholder Yield % | 0.58 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.77 | |||||
| Operating Margin % | 9.39 | |||||
| Net Margin % | 6.7 | |||||
| FCF Margin % | 1.05 | |||||
| ROE % | 12.34 | |||||
| ROA % | 5.88 | |||||
| ROIC % | 7.8 | |||||
| ROC (Joel Greenblatt) % | 12.49 | |||||
| ROCE % | 14.99 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.1 | |||||
| PE Ratio without NRI | 16.1 | |||||
| PEG Ratio | 6.19 | |||||
| PS Ratio | 1.08 | |||||
| PB Ratio | 1.87 | |||||
| Price-to-Tangible-Book | 1.88 | |||||
| Price-to-Free-Cash-Flow | 102.43 | |||||
| Price-to-Operating-Cash-Flow | 14.49 | |||||
| EV-to-EBIT | 12.39 | |||||
| EV-to-EBITDA | 8.74 | |||||
| EV-to-Revenue | 1.36 | |||||
| EV-to-FCF | 119.46 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.45 | |||||
| Price-to-Graham-Number | 1.16 | |||||
| Earnings Yield (Greenblatt) % | 8.07 | |||||
| FCF Yield % | 0.98 | |||||
| Forward Rate of Return (Yacktman) % | -2.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SMS Lifesciences India Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,266.57 | ||
| EPS (TTM) (₹) | 72.38 | ||
| Beta | 0.32 | ||
| Volatility % | 46.77 | ||
| 14-Day RSI | 42.09 | ||
| 14-Day ATR (₹) | 67.112181 | ||
| 20-Day SMA (₹) | 1238.3325 | ||
| 12-1 Month Momentum % | 173.95 | ||
| 52-Week Range (₹) | 488.05 - 1747.85 | ||
| Shares Outstanding (Mil) | 3.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SMS Lifesciences India Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SMS Lifesciences India Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
SMS Lifesciences India Ltd Frequently Asked Questions
What is SMS Lifesciences India Ltd(BOM:540679)'s stock price today?
The current price of BOM:540679 is ₹1164.85. The 52 week high of BOM:540679 is ₹1747.85 and 52 week low is ₹488.05.
When is next earnings date of SMS Lifesciences India Ltd(BOM:540679)?
The next earnings date of SMS Lifesciences India Ltd(BOM:540679) is .
Does SMS Lifesciences India Ltd(BOM:540679) pay dividends? If so, how much?
The Dividend Yield %  of SMS Lifesciences India Ltd(BOM:540679) is 0.13% (As of Today), Highest Dividend Payout Ratio of SMS Lifesciences India Ltd(BOM:540679) was 0.05. The lowest was 0.02. And the median was 0.05. The  Forward Dividend Yield % of SMS Lifesciences India Ltd(BOM:540679) is 0.13%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers